Biomarkers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors

被引：1
|
作者：
Tripathi, Abhishek [1 ]
Lin, Edwin [2 ]
Agarwal, Neeraj [2 ]
机构：
[1] Univ Oklahoma, Stephenson Canc Ctr, Oklahoma City, OK USA
[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷
关键词：
SENESCENCE; FIBROBLASTS;
D O I：
10.21037/atm.2019.07.13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Cost effectiveness of immune checkpoint inhibitors in combination with targeted therapies in metastatic renal cell carcinoma
    Mason, N.
    Kim, Y.
    Shah, S.
    Adashek, J. J.
    Manley, B. J.
    Spiess, P. E.
    Chahoud, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S692 - S692
  • [32] Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines
    Resch, I.
    Bruchbacher, A.
    Franke, J.
    Fajkovic, H.
    Remzi, M.
    Shariat, S. F.
    Schmidinger, M.
    ESMO OPEN, 2021, 6 (04)
  • [33] T-cell checkpoint inhibitors in metastatic renal cell carcinoma
    Gruenwald, Viktor
    CURRENT OPINION IN UROLOGY, 2015, 25 (05) : 411 - 415
  • [34] Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
    Revati Sharma
    Elif Kadife
    Mark Myers
    George Kannourakis
    Prashanth Prithviraj
    Nuzhat Ahmed
    Journal of Experimental & Clinical Cancer Research, 40
  • [35] Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
    Sharma, Revati
    Kadife, Elif
    Myers, Mark
    Kannourakis, George
    Prithviraj, Prashanth
    Ahmed, Nuzhat
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [36] Outcome with immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines
    Bruchbacher, Andreas
    Franke, Johannes
    Alic, Zumreta
    Nachbargauer, Sebastian
    Fajkovic, Harun
    Remzi, Mesut
    Schmidinger, Manuela
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [37] Metastatic renal medullary and collecting duct carcinoma in the era of antiangiogenic and immune checkpoint inhibitors: A multicentric retrospective study
    Guillaume, Z.
    Colomba-Blameble, E.
    Barthelemy, P.
    Saldana, C.
    Dumont, C.
    Laguerre, B.
    Maillet, D.
    Vicier, C.
    Rolland, F.
    Borchiellini, D.
    Thouvenin, J.
    Albiges, L.
    Auclin, E.
    Oudard, S.
    Thibault, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S574 - S574
  • [38] Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study
    Guillaume, Zoe
    Colomba, Emeline
    Thouvenin, Jonathan
    Saldana, Carolina
    Campedel, Luca
    Dumont, Clement
    Laguerre, Brigitte
    Maillet, Denis
    Vicier, Cecile
    Rolland, Frederic
    Borchiellini, Delphine
    Barthelemy, Philippe
    Albiges, Laurence
    Auclin, Edouard
    Dugage, Matthieu Roulleaux
    Oudard, Stephane
    Thibault, Constance
    CANCERS, 2022, 14 (07)
  • [39] Urothelial carcinoma in the era of immune checkpoint inhibitors
    Khalife, Nadine
    Chahine, Claude
    Kordahi, Manal
    Felefly, Tony
    Kourie, Hampig Raphael
    Saleh, Khalil
    IMMUNOTHERAPY, 2021, 13 (11) : 953 - 964
  • [40] Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Gao, Xin
    McDermott, David F.
    CANCER JOURNAL, 2018, 24 (04): : 171 - 179
12345